Rheumatoid Arthritis News

 
 
  • Benzodiazepines Plus Opioids, Common Combo in Alzheimer's Benzodiazepines and opioids are frequently coprescribed for patients with Alzheimer's disease, putting them at increased risk for osteoporosis, falls, and fractures.
  • Questions Remain About Etanercept to Biosimilar Switch Nationwide registry data from patients with inflammatory arthritis showed many had similar outcomes with biosimilar, but the study did not show conclusively that the two drugs are interchangeable.
  • Walmart, Home Depot Adopt Health Insurer Tactic in Drug Copay Battle Walmart and Home Depot, two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications.
  • AIPM 2018Clinicians Hungry for Education on Diet for Pain Management Clinicians taking the course report that it boosts their comfort level and confidence in discussing nutrition with their pain patients.
  • FDA Approves Novartis' Copy Of AbbVie Bestseller Humira The U.S. Food and Drug Administration (FDA) has approved Novartis AG's copy of Humira, the world's bestselling prescription medicine developed by U.S.-based AbbVie Inc, the agency's website showed on Wednesday.
  • ACR 2018Achilles Tendon Damage Prevalent in Rheumatoid Arthritis Enthesitis in the Achilles tendon is common in patients with rheumatoid arthritis, new research shows, and detection with ultrasound can lead to early intervention to reduce mechanical stress.
  • Art, Science Collide to Inspire Clinical Practice Graphic artist Alece Birnbach has been asking physicians about their practices, their challenges, and what they think medicine will look like by the year 2030. Here is what they unearthed.
  • October 23 Daily Buzz at ACR 2018 Today at ACR 2018, a smaller-than-expected effect of bDMARDs in poor countries was reported, and art and rheumatology intersected to look into the future.
  • Missed Rheumatoid Arthritis Treatment Targets Challenge Physicians Guidelines for rheumatoid arthritis call for testing and treatment until low disease activity is achieved, but an analysis of 50,000 patients from the RISE registry point to missed opportunities.
  • ACR 2018Apps, Wearables Help Physicians and Patients Track Symptoms When patients track symptoms of rheumatoid arthritis in an app that connects to their health record, treatment decisions are better, but technology is not for everyone, a researcher cautions.
  • October 22 Daily Buzz at ACR 2018 A session on the treat-to-target goal in patients with rheumatoid arthritis and an abstract making the case that patients are not whiners and complainers made news today at the meeting.
  • ACR 2018High-Dose Flu Vaccine Boosts Immune Response in RA Patients A flu vaccine used in elderly patients is safe and more effective than the traditional vaccine in patients with rheumatoid arthritis, who are particularly susceptible to influenza, new research shows.
  • October 21 Daily Buzz at ACR 2018 At the American College of Rheumatology annual meeting: Scientific trial results publish plus an opening lecture featuring a heartfelt patient story.
  • October 20 Daily Buzz at ACR 2018 Conference attendees have fired off nearly 950 tweets in the past 24 hours, and many specialists are talking about gout.
  • Amgen, Novartis Kick Off Fight for AbbVie Blockbuster Drug in EU Rival versions of the world's top-selling drug, AbbVie's Humira (adalimumab), went on sale in Europe on Tuesday, years ahead of similar cut-price copies being available in the United States.
  • Takeaways From 15 Years of Biologics at ACR Specialists will track major advances in the treatment of rheumatoid arthritis over recent years and discuss implications for the future at the upcoming American College of Rheumatology meeting.
  • ACR 2018Checkpoint Inhibitors, Wearables Among Hot Topics at ACR Immunotherapy has opened up exciting options for cancer treatment, but it can also lead to significant complications, which specialists will assess at the American College of Rheumatology meeting.
  • More Evidence TNF Inhibitors Raise Risk of Peripheral Neuropathy A large epidemiological study provides more evidence of a link between tumor necrosis factor inhibitors (TNFi) and peripheral neuropathy (PN).
  • Arthritis Tied to Higher Risk for Anxiety, Depression 'The high prevalence of symptoms of anxiety and depression among adults with arthritis warrants awareness, screening, and subsequent treatment of these conditions,' researchers say.
  • Childhood Secondhand Smoke Exposure Tied to Arthritis in Adulthood Women exposed to secondhand smoke as children may be more likely to develop rheumatoid arthritis than people who didn't breathe cigarette fumes growing up, a French study suggests.
оксандролон для женщин

http://pharmacy24.com.ua

http://pillsbank.net